Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: Report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011)

Diagnostic Microbiology and Infectious Disease

Volumn 79, Issue 4, 2014, Pages 463-467

  Biedenbach, Douglas J ^a   Bouchillon, Samuel K ^a   Hoban, Daryl J ^a   Hackel, Meredith ^a   Phuong, Doan Mai ^b   Nga, Tran Thi Thanh ^c   Phuong, Nguyen Tran My ^d   Phuong, Tran Thi Lan ^e   Badal, Robert E ^a  

^a International Health Management Associates   (United States)

^b BACH MAI HOSPITAL   (Viet Nam)

^c CHO RAY HOSPITAL   (Viet Nam)

^d Binh Dan Hospital   (Viet Nam)

^e VIET DUC HOSPITAL   (Viet Nam)

Author keywords

ESBL; Resistance; SMART study; Vietnam

Indexed keywords

AMIKACIN; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM; CARBAPENEM DERIVATIVE;

ABDOMINAL INFECTION; ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENZYME ANALYSIS; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; GRAM NEGATIVE AEROBIC RODS AND COCCI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; VIET NAM; ANTIBIOTIC RESISTANCE; CLASSIFICATION; CROSS INFECTION; DRUG EFFECTS; GENETICS; GRAM NEGATIVE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; INTRAABDOMINAL INFECTIONS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTRAABDOMINAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; VIETNAM;

EID: 84904121780     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.05.009     Document Type: Article

References (29)

1. Alexander J.W., Solomkin J.S., Edwards M.J. Updated recommendations for control of surgical site infections. Ann Surg 2011, 253:1082-1093.
2. Baquero F., Hsueh P.R., Paterson D.L., Rossi F., Bochicchio G.V., Gallagher G., et al. In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect 2009, 10:99-104.
3. Chanawong A., M'Zali F.H., Heritage J., Lulitanond A., Hawkey P.M. SHV-12, SHV-5, SHV2a and VEB-1 extended-spectrum beta-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand. J Antimicrob Chemother 2001, 48:839-852.
4. Chanawong A., M'Zali F.H., Heritage J., Xiong J.H., Hawkey P.M. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 2002, 46:630-637.
5. Chen W.Y., Jang T.N., Huang C.H., Hsueh P.R. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002-2006. J Microbiol Immunol Infect 2009, 42:317-323.
6. Chen Y.H., Hsueh P.R., Badal R.E., Hawser S.P., Hoban D.J., Bouchillon S.K., et al. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect 2011, 62:280-291.
7. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-Ninth Edition. Document M07-A9 2012, CLSI, Wayne, PA.
8. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Supplement. CLSI document M100- S22 2012, Wayne, PA, CLSI.
9. Dallenne C., Da Costa A., Decre D., Favier C., Arlet G. Development of a set of multiplex PCT assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010, 65:490-495.
10. Global Antibiotic Resistance Partnership. First report on antibiotic use and resistance in Vietnam hospitals in 2008-2009. A report from the Ministry of Health of the Socialist Republic of Vietnam in collaboration with the Global Antibiotic Resistance Partnership and Oxford University Clinical Research Unit ; 2010. http://benhnhietdoi.vn/data/files/documents/Report_on_antibiotics_use_and_resistance_in_15_hospitals_in_2008-2009.pdf.
11. Hawkey P.M. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 2008, 14(Suppl. 1):159-165.
12. Hoang T.H., Wertheim H., Minh N.B., et al. Carbapenem resistant Escherichia coli and Klebsiella pneumoniae containing New Delhi Betallo-Beta-Lactamase isolated from two patients in Vietnam. J Clin Microbiol 2013, 51(1):373-374.
13. Hsueh P.R., Hawkey P.M. Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia. Int J Antimicrob Agents 2007, 30:129-133.
14. Johansson M., Phuong D.M., Walther S.M., Hanberger H. Need for improved antimicrobial and infection control stewardship in Vietnamese intensive care units. Trop Med Int Health 2011, 16:737-743.
15. Jones S.L., Nguyen V.K., Nguyen T.M.P., Athan E. Prevalence of multiresistant Gram-negative organisms in a surgical hospital in Ho Chi Minh City, Vietnam. Trop Med Int Health 2006, 11:1725-1730.
16. Lascols C., Hackel M., Marshall S.H., Hujer A.M., Bouchillon S., Badal R., et al. Increasing prevalence and dissemination of NDM-1 metallo-beta-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother 2011, 66:1992-1997.
17. Lau Y.J., Chen Y.H., Huang C.T., Lee W.S., Cy Liu, Liu J.W., et al. Role of moxifloxacin for the treatment of community-acquired [corrected] complicated intra-abdominal infections in Taiwan. J Microbiol Immunol Infect 2012, 45:1-6.
18. Livermore D.M. Fourteen years in resistance. Int J Antimicrob Agents 2012, 4:283-294.
19. Mazuski J.E., Sawyer R.G., Nathens A.B., DiPiro J.T., Schein M., Kudsk K.A., et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect 2002, 3:161-173.
20. Mazuski J.E., Sawyer R.G., Nathens A.B., DiPiro J.T., Schein M., Kudsk K.A., et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect 2002, 3:175-233.
21. Mulvey M.R., Bryce E., Boyd D., et al. Ambler class A extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother 2004, 48:1204-1214.
22. Nuesch-Inderbinen M.T., Hachler H., Kayser F.H. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the Etest. Eur J Clin Microbiol Infect Dis 1996, 15:398-402.
23. Perez-Perez F.J., Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
24. Solomkin J.S., Mazuski J.E., Bradley J.S., Rodvold K.A., Goldstein E.J., Baron E.J., et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) 2010, 11:79-109.
25. Solomkin J.S., Mazuski J.E., Bradley J.S., Rodvold K.A., Goldstein E.J., Baron E.J., et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:133-164.
26. Speldooren V., Hyem B., Labia R., et al. Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR. Antimicrob Agents Chemother 1998, 424:879-884.
27. Turner P. Extended-spectrum β-lactamases. Clin Infect Dis 2005, 41(Suppl. 4):273-275.
28. Yigit H., Queenan A.M., Anderson G.J., et al. Novel carbapenem-hydrolysing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001, 45:1151-1161.
29. Yu W.L., Chuang Y.C., Walther-Rasmussen J. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control. J Microbiol Immunol Infect 2006, 39:264-277.